David A. Siegel Cv Rx, Inc. Transaction History
Two Sigma Advisers, LP
- $47 Billion
- Q3 2025
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Cv Rx, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 20,800 shares of CVRX stock, worth $189,280. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,800
Previous 37,800
44.97%
Holding current value
$189,280
Previous $222,000
27.03%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding CVRX
# of Institutions
96Shares Held
14.3MCall Options Held
59.5KPut Options Held
30.3K-
Johnson & Johnson New Brunswick, NJ4.1MShares$37.3 Million7.51% of portfolio
-
Nea Management Company, LLC Timonium, MD2.03MShares$18.4 Million0.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.09MShares$9.92 Million0.0% of portfolio
-
Black Rock Inc. New York, NY876KShares$7.97 Million0.0% of portfolio
-
Balyasny Asset Management LLC Chicago, IL696KShares$6.34 Million0.01% of portfolio
About CVRx, Inc.
- Ticker CVRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 20,576,200
- Market Cap $187M
- Description
- CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The co...